Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2018 | 12-2017 | 06-2017 | 12-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,700 | 75,816 | 61,200 | 49,179 | 39,142 |
| Marketable Securities | N/A | N/A | N/A | N/A | 129 |
| Inventories | 86,600 | 64,274 | 56,507 | 52,038 | 54,375 |
| Other current assets | 81,600 | 68,126 | 67,269 | 71,667 | 68,809 |
| TOTAL | $247,900 | $208,216 | $184,976 | $172,884 | $162,455 |
| Non-Current Assets | |||||
| PPE Net | 45,300 | 44,478 | 45,197 | 44,172 | 37,718 |
| Intangibles | 709,800 | 372,107 | 396,262 | 397,569 | 360,381 |
| Other Non-Current Assets | 14,300 | 11,433 | 11,634 | 432 | 197 |
| TOTAL | $769,400 | $428,018 | $453,093 | $442,173 | $398,296 |
| Total Assets | $1,017,300 | $636,234 | $638,069 | $615,057 | $560,751 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,200 | N/A | 965 | N/A | 1,648 |
| Accounts payable and accrued liabilities | 33,000 | 63,055 | 21,433 | 61,140 | 24,326 |
| Other current liabilities | 8,800 | 1,290 | 1,617 | 824 | 467 |
| TOTAL | $91,600 | $70,098 | $66,411 | $66,987 | $66,256 |
| Non-Current Liabilities | |||||
| Long Term Debt | 289,900 | N/A | 180,178 | N/A | 154,093 |
| Other Non-Current Liabilities | 33,800 | 215,444 | 37,999 | 196,987 | 8,240 |
| TOTAL | $420,700 | $250,844 | $269,021 | $260,428 | $217,883 |
| Total Liabilities | $512,300 | $320,942 | $335,432 | $327,415 | $284,139 |
| Shareholders' Equity | |||||
| Common Shares | 1,000 | 935 | 932 | 930 | 927 |
| Retained earnings | 125,500 | 121,253 | 107,422 | 95,698 | 93,995 |
| Other shareholders' equity | 19,600 | 18,134 | 20,011 | 16,833 | 7,279 |
| TOTAL | $505,000 | $313,739 | $301,074 | $286,166 | $274,631 |
| Total Liabilities And Equity | $1,017,300 | $634,681 | $636,506 | $613,581 | $558,770 |